Skip to content

Clinical trials

Phase 2 Prostatic Hyperplasia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Phase 2 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20052
20062
20074
20081
20092
20103
20121
20131
20141
20151
20181
20221
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated7
Recruiting3
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
H. Lee Moffitt Cancer Center and Research Institute2
Spectrum Pharmaceuticals, Inc2
VA Office of Research and Development2
Allergan1
Ausio Pharmaceuticals, LLC1
Beth Israel Deaconess Medical Center1
Endeavor Health1
Light Sciences Oncology1
Milkhaus Laboratory1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia27
Prostatic Neoplasms4
Lower Urinary Tract Symptoms3
Eunuchism1
Hematuria1
Muscular Atrophy1
Nocturia1
Prostatism1
Sarcopenia1
Urinary Incontinence1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.